$2.81 Billion is the total value of Carlyle Group Inc.'s 27 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Quidelortho Corp | $1,032,450,763 | -7.0% | 12,460,183 | 0.0% | 36.78% | +11.1% | ||
| ZI | ZoomInfo Technologies Inc | $930,860,088 | +2.8% | 36,662,469 | 0.0% | 33.16% | +22.7% | |
| VTRU | Vitru Ltd | $100,130,930 | -29.6% | 6,246,471 | 0.0% | 3.57% | -15.9% | |
| VRNA | Verona Pharma Plcsponsored ads | $51,877,825 | +5.1% | 2,457,500 | 0.0% | 1.85% | +25.5% | |
| GDS | GDS Hldgs Ltdsponsored ads | $44,758,142 | -41.1% | 4,072,624 | 0.0% | 1.59% | -29.7% | |
| Hillevax Inc | $31,530,035 | +4.8% | 1,838,486 | 0.0% | 1.12% | +25.1% | ||
| INVH | Invitation Homes Inc | $16,426,000 | +10.2% | 477,500 | 0.0% | 0.58% | +31.5% | |
| Jasper Therapeutics Inc | $11,828,553 | -25.0% | 8,761,891 | 0.0% | 0.42% | -10.4% | ||
| CUBE | CubeSmart | $9,847,530 | -3.4% | 220,500 | 0.0% | 0.35% | +15.5% | |
| SPRB | Spruce Biosciences Inc | $6,227,514 | -2.7% | 2,896,518 | 0.0% | 0.22% | +16.2% | |
| ACET | Adicet Bio Inc | $5,119,232 | -57.9% | 2,115,385 | 0.0% | 0.18% | -49.9% | |
| Soleno Therapeutics Inc | $5,094,385 | +100.9% | 1,201,506 | 0.0% | 0.18% | +138.2% | ||
| EM | Smart Sh Global Ltdads | $4,689,593 | -12.2% | 4,810,209 | 0.0% | 0.17% | +5.0% | |
| Effector Therapeutics Inc | $3,954,133 | +134.3% | 4,822,114 | 0.0% | 0.14% | +182.0% | ||
| NCNA | Nucana Plcsponsored adr | $2,600,000 | -18.8% | 3,333,333 | 0.0% | 0.09% | -2.1% | |
| PRTK | Paratek Pharmaceuticals Inc | $2,300,900 | -12.3% | 1,041,131 | 0.0% | 0.08% | +5.1% | |
| Exicure Inc | $368,943 | +52.3% | 281,636 | 0.0% | 0.01% | +85.7% | ||
| Meta Data Limitedsponsored ads | $336,408 | +2.2% | 314,400 | 0.0% | 0.01% | +20.0% | ||
| AGLE | Aeglea Biotherapeutics Inc | $108,225 | +56.8% | 240,500 | 0.0% | 0.00% | +100.0% | |
| MTEM | Molecular Templates Inc | $92,000 | +22.6% | 200,000 | 0.0% | 0.00% | +50.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-04
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Wesco Aircraft Hldgs Inc | 28 | Q4 2019 | 16.8% |
| Seacor Marine Hldgs Inc | 22 | Q3 2023 | 1.1% |
| Enviva Partners LP | 21 | Q2 2020 | 31.5% |
| Enduro Rty Tr | 21 | Q1 2018 | 2.8% |
| USA Compression Partners LP | 20 | Q2 2018 | 28.5% |
| Pattern Energy Group Inc | 20 | Q3 2018 | 16.2% |
| Concord Med Svcs Hldgs Ltd | 19 | Q3 2017 | 1.1% |
| Superior Energy Svcs Inc | 19 | Q3 2017 | 0.7% |
| Cobalt Intl Energy Inc | 17 | Q1 2017 | 11.0% |
| Sequential Brnds Group Inc N | 17 | Q1 2020 | 1.7% |
View Carlyle Group Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Complete Solaria, Inc. | September 22, 2023 | 2,745,879 | 5.7% |
| Carlyle Credit Income Fund | September 14, 2023 | 4,785,628 | 41.0% |
| Vera Therapeutics, Inc. | August 02, 2023 | 1,872,764 | 4.2% |
| Reneo Pharmaceuticals, Inc. | May 09, 2023 | 2,730,457 | 8.2% |
| EXICURE, INC. | April 13, 2023 | 287,137 | 3.4% |
| SPRUCE BIOSCIENCES, INC. | February 23, 2023 | 3,734,518 | 9.2% |
| Vaxcyte, Inc. | February 10, 2023 | 2,070,724 | 2.6% |
| NuCana plc | August 11, 2022 | 3,353,134 | 6.4% |
| 1Life Healthcare Inc | February 11, 2022 | 13,612,681 | 7.1% |
| Atotech Ltd | February 11, 2022 | 153,672,703 | 78.9% |
View Carlyle Group Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-05-14 |
| SC 13D/A | 2024-05-13 |
| 10-Q | 2024-05-07 |
| 13F-HR | 2024-05-03 |
| 4 | 2024-05-03 |
| 4 | 2024-05-03 |
| 4 | 2024-05-03 |
| 4 | 2024-05-03 |
| 4 | 2024-05-03 |
| 4 | 2024-05-03 |
View Carlyle Group Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.